Novel Prognostic Models for Myelodysplastic Syndromes.

Abstract excerpt

Myelodysplastic syndromes are disorders of clonal myelopoiesis having a range of clinical manifestations, from benign and indolent to aggressive with very poor prognosis. Classifying the likely trajectory of disease within a patient largely guides therapeutic decision making and therefore survival. Traditional methods of risk-stratification systems rely on clinical features: simple blood tests, peripheral smears,...

Topics

Join the communities discussing this publication.

• Computational Biology
• Disease Management
• Disease Susceptibility
• DNA Methylation
• Genetic Heterogeneity